Bullfrog AI Holdings (BFRG) fair value: what the stock is really worth
As of Oct 30, 2026: fair value (intrinsic value) of Bullfrog AI Holdings stock $0.09, price $0.49, upside -82.6%, quality 26 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Bullfrog AI Holdings
BFRG · USOur calculation puts a fair price 83% below what the stock costs today.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 30, 2026.
How to read this chart
45‑month range $0.4285 – $8.74 · fair‑value band $0.0595 – $0.1105 · the $0.4877 price screens above the $0.0850 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 30, 2026.
Every Wednesday you see whether Bullfrog AI is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
Show moreShow less
The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations.
It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases.
The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease.
It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Stock analysis
Bullfrog AI Holdings (BFRG) currently trades at $0.4877, while our model-based Fair Value estimate is $0.0850, 82.6% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Scenario range: $0.0595 (bear) to $0.1105 (bull), the price of $0.4877 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Bullfrog AI Holdings reported revenue of $117K in FY2025 versus $0 in FY2021. Reported net income was −$6.5M in FY2025.
Key figures
Market cap $9.0M Micro · P/S ratio 40.1 · EPS (TTM) $−0.4600 · Return on equity −131% · Return on assets (EBIT) −1,832% · Operating margin −659% · Revenue (TTM) $299K · Revenue growth (YoY) +548%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).
What moves the price
The share trades about 71% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 4% fair-value upside, at −83%, BFRG screens richer than that median.
Fair Value models
All 1 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
BFRG screens overvalued: fair value 83% below the price. Compare with Veeva Systems Inc →
Compare Bullfrog AI Holdings with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 123 stocks
Valuation Multiplesvs Health Information Services median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Price/FCF by industry
- Debt-to-equity by industry
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Veeva Systems Inc VEEV | $310.34 | $341.37 | +10% | vs BFRG |
| HealthEquity, Inc HQY | $101.36 | $111.50 | +10% | vs BFRG |
| Doximity, Inc DOCS | $34.25 | $37.68 | +10% | vs BFRG |
| Inventurus Knowledge Solutions Limited IKS | ₹1,703 | ₹1,873 | +10% | vs BFRG |
| Waystar Holding WAY | $28.02 | $29.10 | +4% | vs BFRG |
| Winning Health Technology Group 300253 | ¥7.10 | ¥3.44 | −52% | vs BFRG |
| Hinge Health, Inc HNGE | $113.90 | $51.25 | −55% | vs BFRG |
| BrightSpring Health Services, Inc BTSG | $58.36 | $25.86 | −56% | vs BFRG |
| Pro Medicus Limited PME | A$196.00 | A$85.12 | −57% | vs BFRG |
| Privia Health Group PRVA | $22.00 | $5.52 | −75% | vs BFRG |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Bullfrog AI Holdings (BFRG) overvalued or undervalued?
What is the fair value of BFRG?
What is the quality score of BFRG?
What is the price target for Bullfrog AI Holdings (BFRG)?
What is the Bullfrog AI Holdings stock forecast for 2026?
What is the revenue of Bullfrog AI Holdings (BFRG)?
What is the intrinsic value of Bullfrog AI Holdings (BFRG)?
Is Bullfrog AI Holdings stock overvalued or undervalued in 2026?
Is fair value the same as the market price of BFRG?
How much is Bullfrog AI Holdings worth?
What do the bullish and bearish scenarios say about BFRG?
How solid is the balance sheet of Bullfrog AI Holdings (BFRG)?
How far is BFRG from its 52-week high?
Which stocks are comparable to Bullfrog AI Holdings?
Is Bullfrog AI Holdings stock attractive at the current price?
How is the fair value of BFRG calculated?
Is it still worth investing in stocks now?
What is the share price of Bullfrog AI Holdings (BFRG)?
What should I pay attention to with Bullfrog AI Holdings right now?
Key figures of Bullfrog AI Holdings
How large is the market capitalisation of Bullfrog AI Holdings (BFRG)?
What is the P/S ratio of Bullfrog AI Holdings (BFRG)?
What are the earnings per share of Bullfrog AI Holdings (BFRG)?
What is the return on equity of Bullfrog AI Holdings (BFRG)?
What is the EBIT return on assets of Bullfrog AI Holdings (BFRG)?
What is the operating margin of Bullfrog AI Holdings (BFRG)?
How fast is revenue growing at Bullfrog AI Holdings (BFRG)?
How much free cash flow does Bullfrog AI Holdings (BFRG) generate?
How much net cash does Bullfrog AI Holdings (BFRG) hold?
Watch Bullfrog AI Holdings in the live analysis
One click puts Bullfrog AI Holdings on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.